A randomised, placebo-controlled study of the effect of three herbal extracts (Condothymus capitatis, Origanum dictamnus and Salvia fruticosa/promifera) on the inflammatory reaction during infection of the upper respiratory tract

Completed

• Conditions: Infections and Infestations, Upper Respiratory Tract Infections; Respiratory; Upper Respiratory Tract Infection

• Registration Number: ISRCTN09700238
• Lead Sponsor: Olvos Science SA (Greece)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-06-27
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Adults >18 years
2. Signed and dated informed consent form
3. Capability and availability to visit one of the study centers within 24 hours of onset of URTI symptoms (common cold)

Exclusion Criteria

1. Pregnancy or lactation
2. Antibiotics use (any type and route of administration) up to 14 days prior to inclusion in the study
3. Use of antiretroviral pharmaceutical medications or herbs from Crete
4. Participation in interventional clinical study during the period of the study conduct
5. Requirement for long-term administration of aspirin, non-steroid anti-inflammatory agents or other antipyretic/analgesic medicines (such as paracetamol). Use of low dosage aspirin for the prevention of cardiovascular events is excluded
6. Use of immunosuppressive medication including the systemic administration of steroids or other cancer therapy, and/or the presence of neoplastic disease or AIDS
7. Planned surgery or other invasive procedure requiring systemic anesthesia during the period of the study conduct

Study & Design

• Study Type: Interventional
• Study Design: Not specified